Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial

1. Phytochemicals Composition and Bioactivities of <i>Fagopyrum esculentum</i> Moench. Extract and Fractions With In Silico Insights

   Mehak Thakur, Rachna Verma, Dinesh Kumar +3

   МақолаSeed and Plant BiochemistryChemistry & Biodiversity20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.007992

2. Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials

   Haniyeh Barzgar, Darmadi Darmadi, Jabbarova Nafisa +2

   Шарҳ мақолаDiabetes Treatment and ManagementClinica Chimica Acta20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000250